MannKind | MNKD - Ebit





Ebit Veränderung Datum
Adma Biologics USD 59.23M 3.52M 2026-03
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Insmed USD -101.31M 98.97M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -31.88M 19.79M 2026-03
MannKind USD -68.23M 8.76M 2026-06
Merck USD 840M 2.72B 2026-06
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Novavax USD 20.94M 100.32M 2025-12
Novo Nordisk DKK 5.25B 60.42B 2026-06
Pfizer USD -180M 5.16B 2026-06
Sanofi EUR 1.12B 811M 2026-06
Xencor USD -36.6M 41.26M 2026-06